×
About 79,602 results

ALLMedicine™ Hepatitis B Center

Research & Reviews  38,173 results

The dynamics and association of B and T cell receptor repertoires upon antibody respons...
https://doi.org/10.1080/21645515.2021.1913028
Human Vaccines & Immunotherapeutics; Zhao M, Li X et. al.

Apr 16th, 2021 - The Hepatitis B (HB) vaccine is efficacious in preventing hepatitis B virus infection. However, the association between antibody response to the HB vaccine and dynamic immune repertoire changes in different cell subsets remains unclear. Nine healt...

Effectiveness of hepatitis B vaccination in chronic HCV patients after successful gener...
https://doi.org/10.1111/tmi.13588
Tropical Medicine & International Health : TM & IH; Abd El-Wahab EW, Metwally M et. al.

Apr 16th, 2021 - Previous reports show conflicting results regarding hepatitis B virus (HBV) vaccine efficacy in Hepatitis C virus (HCV) infected individuals and in those with isolated hepatitis B core antibodies (HBcAb). We aimed to evaluate the effectiveness of ...

LncRNA XIST upregulates TRIM25 via negatively regulating miR-192 in hepatitis B virus-r...
https://doi.org/10.1186/s10020-021-00278-3 10.18632/oncotarget.26263 10.1016/j.ejrad.2018.01.025 10.1016/j.ejrad.2019.01.018 10.1002/cpt.355 10.1016/j.bpg.2014.08.007 10.1186/s12885-017-3216-6 10.1101/gr.178194.114 10.1002/hep.27969 10.1038/nrm.2016.126 10.1016/j.jhep.2015.05.008 10.1016/j.jhep.2018.03.019 10.1371/journal.pgen.1005726 10.1158/0008-5472.CAN-18-1675 10.1098/rstb.2017.0074 10.1002/jcb.26540 10.1016/j.jhep.2016.02.021 10.1016/j.lfs.2018.02.006 10.1016/j.canlet.2018.01.036 10.18632/oncotarget.6603 10.3892/or.2015.4030 10.1038/s41467-019-14190-2 10.1016/j.immuni.2015.04.022 10.1016/j.clinre.2016.09.002 10.18632/oncotarget.13670 10.1177/1010428317690999 10.1016/j.jhep.2015.01.002 10.2174/1874357901812010026 10.1177/1533034615595903 10.1038/nrg.2015.10 10.18632/oncotarget.19154 10.1111/liv.12807 10.1016/j.gene.2016.07.055 10.1038/s41388-017-0095-x 10.1038/nrg.2016.20 10.1016/j.celrep.2017.07.052 10.1016/j.ebiom.2018.12.061 10.1002/jcb.25988 10.1038/ncomms11169 10.1159/000480419 10.1007/s12094-014-1194-6 10.1016/j.ccell.2015.09.006 10.1016/j.semcdb.2018.07.013 10.1016/j.canlet.2014.12.051 10.1002/hep.28123 10.1002/iub.1661 10.1042/BSR20191418 10.2147/OTT.S241011 10.18632/oncotarget.7181 10.1038/srep19070
Molecular Medicine (Cambridge, Mass.); Wang J, Yin G et. al.

Apr 16th, 2021 - Long non-coding RNA (lncRNA) XIST has been implicated in the progression of a variety of tumor diseases. The purpose of this study was to explore the molecular role of lncRNA XIST in human hepatitis B virus (HBV)-related hepatocellular carcinoma (...

Surgical plume from tissue infected with human hepatitis B virus can contain viral subs...
https://doi.org/10.1080/13645706.2021.1910848
Minimally Invasive Therapy & Allied Technologies : MITAT ... Hirota M, Takahashi H et. al.

Apr 15th, 2021 - Evidence on the biological danger associated with surgical plume is lacking. We examined whether surgical plume, generated by the energy devices ultrasonically activated scalpel (US) or electrocautery (EC) contains virus-related substances. Experi...

Screening for Hepatitis B Virus Infection in Adolescents and Adults: Recommendation Sta...
https://www.ncbi.nlm.nih.gov/pubmed/33856166
American Family Physician;

Apr 15th, 2021 - Screening for Hepatitis B Virus Infection in Adolescents and Adults: Recommendation Statement.|2021||

see more →

Guidelines  147 results

Hepatocellular carcinoma
https://www.nature.com/articles/s41572-020-00240-3
Nature Reviews; Llovet JM

Jan 20th, 2021 - Liver cancer remains a global health challenge, with an estimated incidence of >1 million cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cancer and accounts for ~90% of cases. Infection by hepatitis B virus and hepa...

Chemical Risk Factors of Primary Liver Cancer: An Update
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801911/
Hepatic Medicine: Evidence and Research; Barsouk A, Thandra KC et. al.

Jan 4th, 2021 - Primary liver cancer has the sixth highest incidence and fourth highest cancer mortality worldwide. Hepatitis B is the leading cause of liver cancer, though its incidence is decreasing with vaccination. Alcohol is the leading cause of liver transp...

Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Serv...
https://doi.org/10.1001/jama.2020.22980
JAMA , Krist AH et. al.

Dec 15th, 2020 - An estimated 862 000 persons in the US are living with chronic infection with hepatitis B virus (HBV). Persons born in regions with a prevalence of HBV infection of 2% or greater, such as countries in Africa and Asia, the Pacific Islands, and part...

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: A...
https://doi.org/10.1200/JCO.20.01757
Journal of Clinical Oncology : Official Journal of the Am... Hwang JP, Feld JJ et. al.

Jul 27th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management. All patients anticipating systemic anticancer therapy should be tested for HBV by 3 tests-hepatitis B surface an...

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update
https://ascopubs.org/doi/full/10.1200/JCO.20.01757
Journal of Clinical Oncology; Hwang JP

Jul 26th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management.

see more →

Drugs  247 results see all →

Clinicaltrials.gov  39,497 results

The dynamics and association of B and T cell receptor repertoires upon antibody respons...
https://doi.org/10.1080/21645515.2021.1913028
Human Vaccines & Immunotherapeutics; Zhao M, Li X et. al.

Apr 16th, 2021 - The Hepatitis B (HB) vaccine is efficacious in preventing hepatitis B virus infection. However, the association between antibody response to the HB vaccine and dynamic immune repertoire changes in different cell subsets remains unclear. Nine healt...

Effectiveness of hepatitis B vaccination in chronic HCV patients after successful gener...
https://doi.org/10.1111/tmi.13588
Tropical Medicine & International Health : TM & IH; Abd El-Wahab EW, Metwally M et. al.

Apr 16th, 2021 - Previous reports show conflicting results regarding hepatitis B virus (HBV) vaccine efficacy in Hepatitis C virus (HCV) infected individuals and in those with isolated hepatitis B core antibodies (HBcAb). We aimed to evaluate the effectiveness of ...

LncRNA XIST upregulates TRIM25 via negatively regulating miR-192 in hepatitis B virus-r...
https://doi.org/10.1186/s10020-021-00278-3 10.18632/oncotarget.26263 10.1016/j.ejrad.2018.01.025 10.1016/j.ejrad.2019.01.018 10.1002/cpt.355 10.1016/j.bpg.2014.08.007 10.1186/s12885-017-3216-6 10.1101/gr.178194.114 10.1002/hep.27969 10.1038/nrm.2016.126 10.1016/j.jhep.2015.05.008 10.1016/j.jhep.2018.03.019 10.1371/journal.pgen.1005726 10.1158/0008-5472.CAN-18-1675 10.1098/rstb.2017.0074 10.1002/jcb.26540 10.1016/j.jhep.2016.02.021 10.1016/j.lfs.2018.02.006 10.1016/j.canlet.2018.01.036 10.18632/oncotarget.6603 10.3892/or.2015.4030 10.1038/s41467-019-14190-2 10.1016/j.immuni.2015.04.022 10.1016/j.clinre.2016.09.002 10.18632/oncotarget.13670 10.1177/1010428317690999 10.1016/j.jhep.2015.01.002 10.2174/1874357901812010026 10.1177/1533034615595903 10.1038/nrg.2015.10 10.18632/oncotarget.19154 10.1111/liv.12807 10.1016/j.gene.2016.07.055 10.1038/s41388-017-0095-x 10.1038/nrg.2016.20 10.1016/j.celrep.2017.07.052 10.1016/j.ebiom.2018.12.061 10.1002/jcb.25988 10.1038/ncomms11169 10.1159/000480419 10.1007/s12094-014-1194-6 10.1016/j.ccell.2015.09.006 10.1016/j.semcdb.2018.07.013 10.1016/j.canlet.2014.12.051 10.1002/hep.28123 10.1002/iub.1661 10.1042/BSR20191418 10.2147/OTT.S241011 10.18632/oncotarget.7181 10.1038/srep19070
Molecular Medicine (Cambridge, Mass.); Wang J, Yin G et. al.

Apr 16th, 2021 - Long non-coding RNA (lncRNA) XIST has been implicated in the progression of a variety of tumor diseases. The purpose of this study was to explore the molecular role of lncRNA XIST in human hepatitis B virus (HBV)-related hepatocellular carcinoma (...

Surgical plume from tissue infected with human hepatitis B virus can contain viral subs...
https://doi.org/10.1080/13645706.2021.1910848
Minimally Invasive Therapy & Allied Technologies : MITAT ... Hirota M, Takahashi H et. al.

Apr 15th, 2021 - Evidence on the biological danger associated with surgical plume is lacking. We examined whether surgical plume, generated by the energy devices ultrasonically activated scalpel (US) or electrocautery (EC) contains virus-related substances. Experi...

Screening for Hepatitis B Virus Infection in Adolescents and Adults: Recommendation Sta...
https://www.ncbi.nlm.nih.gov/pubmed/33856166
American Family Physician;

Apr 15th, 2021 - Screening for Hepatitis B Virus Infection in Adolescents and Adults: Recommendation Statement.|2021||

see more →

News  1,507 results

Treatment Paradigm for Chronic HBV in Flux
https://www.medscape.com/viewarticle/948611

Apr 1st, 2021 - These days deciding when to stop targeted treatment for chronic hepatitis B is a bigger challenge than knowing when to start, Norah A. Terrault, MD, MPH, observed at the Gastroenterology Updates, IBD, Liver Disease Conference. That's because the t...

Progress and Challenges in US Perinatal HBV Prevention Program
https://www.medscape.com/viewarticle/945121

Feb 2nd, 2021 - NEW YORK (Reuters Health) - The United States has made progress in identifying infants born to hepatitis B surface antigen (HBsAg)-positive women and getting them vaccinated. Yet, there is also substantial room for improvement, including closing t...

Hepatocellular carcinoma
https://www.nature.com/articles/s41572-020-00240-3
Nature Reviews; Llovet JM

Jan 20th, 2021 - Liver cancer remains a global health challenge, with an estimated incidence of >1 million cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cancer and accounts for ~90% of cases. Infection by hepatitis B virus and hepa...

Eliminating Hepatitis by 2030: HHS Releases New Strategic Plan
https://www.medscape.com/viewarticle/944180

Jan 14th, 2021 - In an effort to counteract alarming trends in rising hepatitis infections, the U.S. Department of Health and Human Services has developed and released its Viral Hepatitis National Strategic Plan 2021-2025, which aims to eliminate viral hepatitis i...

Chemical Risk Factors of Primary Liver Cancer: An Update
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801911/
Hepatic Medicine: Evidence and Research; Barsouk A, Thandra KC et. al.

Jan 4th, 2021 - Primary liver cancer has the sixth highest incidence and fourth highest cancer mortality worldwide. Hepatitis B is the leading cause of liver cancer, though its incidence is decreasing with vaccination. Alcohol is the leading cause of liver transp...

see more →

Patient Education  31 results see all →